Patient safety in medical research is paramount, as it ensures that individuals participating in clinical trials are adequately protected from potential harm.Recent federal funding cuts, which have halted over $2 billion in research grants to institutions like Harvard, pose significant threats to the rigorous oversight mechanisms that safeguard research participants’ rights and welfare.